No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Champions Oncology | 10-K: Annual report
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating, Announces Target Price $6
Earnings Call Summary | Champions Oncology(CSBR.US) Q4 2024 Earnings Conference
Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript
Champions Oncology Q4 2024 Adj EPS $0.01 Beats $(0.16) Estimate, Sales $14.001M Beat $12.692M Estimate
Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Posts Q4 EPS $0.01